Determination of free cyano-cobinamide (cas 13497-85-3) in swine and rabbit plasma by liquid chromatography tandem mass spectrometry
-
Add time:08/09/2019 Source:sciencedirect.com
In recent years, Cobinamide (Cbi) has shown promise as a therapeutic for cyanide poisoning. There are several forms of Cbi based on the identity of the ligands bound to the cobalt in Cbi and these different forms of Cbi have divergent behavior (e.g., the aquo and hydroxo forms of Cbi readily bind to proteins, limiting their distribution significantly, whereas [Cbi(CN)2] does not). While current analysis techniques only measure total Cbi, methods to elucidate the behavior of ‘available’ Cbi versus cyanide-complexed Cbi would be valuable for biomedical and pharmacokinetic studies. Therefore, a method was developed for the analysis of cyanide-complexed Cbi in plasma via liquid chromatography tandem mass spectrometry (LC-MS-MS). Plasma samples were prepared by denaturing proteins with 10% ammonium hydroxide in acetonitrile. The resulting mixture was centrifuged, and the supernatant was removed, dried, and reconstituted. Cyanide-complexed Cbi was then analyzed via LC-MS-MS. The limit of detection was 0.2 μM, and the linear dynamic range was between 1 and 200 μM. The accuracy was 100 ± 17% and the precision, measured by relative standard deviation (%RSD), was ≤18.5%. Carryover, a severe problem when analyzing Cbi via liquid chromatography was eliminated using a polymeric-based stationary phase (PLRP-S) and a controlled washing protocol. The method allowed evaluation of the cyanide-bound and ‘available’ Cbi from treated animals and, when paired with a method for total Cbi analysis, allows for estimation of Cbi utilization when treating cyanide poisoning.
We also recommend Trading Suppliers and Manufacturers of cobinamide (cas 13497-85-3). Pls Click Website Link as below: cas 13497-85-3 suppliers
Prev:Mechanistic basis of vitamin B12 and cobinamide (cas 13497-85-3) salvaging by the Vibrio species
Next:Comparative study of reaction of cobalamin and cobinamide (cas 13497-85-3) with thiocyanate) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Development of a cobinamide (cas 13497-85-3)-based end-of-service-life indicator for detection of hydrogen cyanide gas08/17/2019
- cobinamide (cas 13497-85-3) chemistries for photometric cyanide determination. A merging zone liquid core waveguide cyanide analyzer using cyanoaquacobinamide (cas 13497-85-3)08/16/2019
- Simultaneous determination of 3-mercaptopyruvate and cobinamide (cas 13497-85-3) in plasma by liquid chromatography–tandem mass spectrometry08/15/2019
- Intramuscular cobinamide (cas 13497-85-3) Sulfite in a Rabbit Model of Sublethal Cyanide Toxicity08/14/2019
- Intravenous cobinamide (cas 13497-85-3) Versus Hydroxocobalamin for Acute Treatment of Severe Cyanide Poisoning in a Swine (Sus scrofa) Model08/13/2019
- Inhibition of nitric oxide synthase by cobalamins and cobinamide (cas 13497-85-3)s08/12/2019
- High performance liquid chromatography tandem mass spectrometry assay for the determination of cobinamide (cas 13497-85-3) in pig plasma08/11/2019
- Comparative study of reaction of cobalamin and cobinamide (cas 13497-85-3) with thiocyanate08/10/2019
- Mechanistic basis of vitamin B12 and cobinamide (cas 13497-85-3) salvaging by the Vibrio species08/08/2019


